HPV vaccine prevents cancer, but usage remains low

The HPV vaccine can prevent six types of cancer, including oropharyngeal cancer, but its usage remains low in the U.S. due to misinformation and vaccine hesitancy. Recent data shows only 61% of adolescents have completed the vaccination series. Robert F. Kennedy Jr., the new U.S. Health Secretary, has been criticized for spreading false claims about the HPV vaccine, which may further reduce vaccination rates. His confirmation hearings revealed a lack of support for established vaccine safety research. Despite the vaccine's effectiveness, barriers such as cultural stigma and misinformation hinder its promotion. Health experts emphasize the need for better education on the vaccine's benefits to improve vaccination rates and combat cancer.